Efficacy and Safety of Hemostatic Methods in Distal Radial Artery Approach for Cardiac Catheterization

NCT ID: NCT05966376

Last Updated: 2023-09-21

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 482 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2022-02-01
• Study Completion Date: 2023-12-01

Brief Summary

Comparison of PreludeSYNC distal and Modified Terumo Radial Band in patients with distal radial approach.

Detailed Description

INTRODUCTION AND BACKGROUND

Distal radial access at the level of the anatomical snuffbox and dorsal region of the hand has currently positioned itself as a viable and safe approach for procedures in interventional cardiology, whether diagnostic, simple, or complex angioplasties. We know that this approach method mainly reduces the occlusion rate of the proximal radial artery, among other advantages; however, we still do not have scientific evidence on the various hemostasis methods for this approach. Practice varies between centers and countries and hemostasis methods vary from an elastic compression bandage to the use of devices manufactured specifically for this approach such as the PreludeSYNC DISTAL or modification of devices manufactured for proximal radial hemostasis such as the TR band. In this clinical trial, we intend to analyze the efficacy and safety of two hemostasis methods in patients who require an interventional procedure (PredludeSYNC DISTAL vs modified TR band), to date, there is no clinical trial that compares these methods face to-face in relation to their efficacy and safety. Retrospective studies indicate that both methods are effective in reducing radial artery occlusion and are safe in reducing the bleeding/hematoma rate.

THE PURPOSE OF THE STUDY To compare the efficacy (distal radial artery occlusion) and safety (hematoma/bleeding) of two devices of distal radial hemostasis (PreludeSYNC distal and TR band) in patients undergoing percutaneous coronary intervention.

STUDY DESIGN Experimental, randomized, prospective, longitudinal, prolective, and comparative.

SUBJECTS OF STUDY Patients from the Ignacio Chávez National Institute of Cardiology who will undergo distal radial percutaneous coronary intervention/angiography.

METHODOLOGY After signing the informed consent, patients will be randomized by balanced block methods to: 1) Hemostasis using the PreludeSYNC distal device, or 2) Hemostasis using the Modified Radial Band device.

PRIMARY OUTCOME To compare the efficacy (distal radial artery occlusion) and safety (hematoma/bleeding) of PreludeSYNC distal versus Modified Terumo Radial Band in distal radial approach.

Conditions

Coronary Intervention; Transradial Approach

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Modified Terumo Radial Band

A standard hemostatic device used for proximal radial approach. The hard plastic component is removed to achieve better attachment in the distal radial approach.

• Clean and dry the puncture site.
• The introducer is withdrawn 2 cm.
• Place the device on the patient's hand depending on the approach side.
• Terumo logo is positioned toward the little finger side.
• The green mark is positioned 1 cm proximal to the puncture site.
• The bands are adjusted and fixed around the wrist.
• The Terumo syringe is filled with 15 ml of air.
• The balloon of the device is slowly inflated through the valve while the introducer is slowly withdrawn simultaneously.
• Once the introducer is completely withdrawn, the balloon continues to be inflated until the absence of bleeding is verified.
• Once hemostasis is achieved, the patient must be able to move his fingers and wrist without bleeding. If bleeding is observed, the balloon is inflated to achieve adequate hemostasis.

Group Type: EXPERIMENTAL

Hemostatic device for distal radial approach.

Intervention Type: DEVICE

Hemostasis after distal radial approach is done with one of two devices, one of them is designed specifically for the distal radial approach; the other is not but a modified technique with the last one could be helpful.

PreludeSYNC distal

A specific hemostatic device, designed for distal radial approach.

• Clean and dry the puncture site.
• Selection and preparation of the PreludeSYNC distal device according to the approach side.
• The introducer is withdrawn 2cm.
• The hemostasis device is placed on the patient's hand.
• Bands position: 1) little finger side; 2) thumb side; 3) between the thumb and the index finger.
• The circular mark of the balloon is positioned 1cm proximal to the puncture site.
• Bands are adjusted and fixed.
• The syringe is filled with 10 ml of air.
• The balloon of the device is slowly inflated while the introducer is slowly withdrawn simultaneously.
• Once the introducer is completely withdrawn, the balloon continues to be inflated until the absence of bleeding is verified.
• Once hemostasis is achieved, the patient must be able to move his fingers and wrist without bleeding. If bleeding is observed, the balloon should be inflated to achieve adequate hemostasis.

Group Type: ACTIVE_COMPARATOR

Hemostatic device for distal radial approach.

Intervention Type: DEVICE

Hemostasis after distal radial approach is done with one of two devices, one of them is designed specifically for the distal radial approach; the other is not but a modified technique with the last one could be helpful.

Interventions

Hemostatic device for distal radial approach.

Hemostasis after distal radial approach is done with one of two devices, one of them is designed specifically for the distal radial approach; the other is not but a modified technique with the last one could be helpful.

Intervention Type: DEVICE

Other Intervention Names

PreludeSYNC distal; Terumo Radial Band

Eligibility Criteria

Inclusion Criteria

• Coronary artery disease including chronic coronary syndrome or acute coronary syndrome.
• Cardiovascular disease that requires coronary angiography in its approach.

Exclusion Criteria

• Cardiogenic shock.
• Lesions in venous or arterial hemoducts.
• Impossibility to provide informed consent.
• Chronic kidney disease on hemodialysis through arteriovenous fistula at the same site where the approach is planned.
• Severe chronic renal failure (GFR less than 30 ml/min/m2)
• Patients diagnosed with cancer.
• Patient with rheumatological and hematological pro-thrombotic disorders.
• Non-hydrophilic radial introducer.
• Failed cannulation of the radial artery with an introducer.
• Successful trans-radial access that is crossed over to the femoral approach.
• Patients with an interventional procedure using a radial approach in the previous 30 days.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Instituto Nacional de Cardiologia Ignacio Chavez

OTHER

Sponsor Role: lead

Responsible Party

Arnoldo Enmanuel Loáisiga Sáenz

Interventional Cardiology

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Instituto Nacional de Cardiologia Ignacio Chávez

Mexico City, , Mexico

Countries

Mexico

Other Identifiers

21-1255

Identifier Type: -

Identifier Source: org_study_id